Attorney General Lisa Madigan announced that Illinois is part of a $465-million settlement between the federal government and other states with Mylan Inc. and its wholly owned subsidiary, Mylan Specialty L.P. ( Mylan ).
The settlement was reached in the wake of allegations that Mylan knowingly underpaid rebates owed to the Medicaid program for EpiPen and EpiPen Jr. ( EpiPen ) dispensed to Medicaid beneficiaries. As part of the settlement, Illinois will receive more than $6.3 million in restitution and other recovery.
Deputy Bureau Chief Heather Tullio D'Orazio, with Madigan's Medicaid Fraud Bureau, handled the investigation and settlement.